Ponatinib (PON) in Patients (pts) with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) and the T315I Mutation (mut): 4-Year Results from OPTIC.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined